Find verified Cenobamate API manufacturers, suppliers, and distributors across the globe. Explore companies that offer high-purity Cenobamate for pharmaceutical use, along with product details, certifications, and reliable sourcing options. Compare prices, check availability, and connect directly with trusted suppliers for Cenobamate API.
Alternate Names: Xcopri, YKP-3089, P85X70RZWS, DTXSID001027948
CAS No: 913088-80-9
PubChem CID: 11962412
Mol Formula: C10H10ClN5O2
Mol Weight: 267.67 g/mol
IUPAC Name: [(1R)-1-(2-chlorophenyl)-2-(tetrazol-2-yl)ethyl] carbamate
API Description: Cenobamate, or YKP-3089, is an antiepileptic drug developed by SK Pharmaceuticals and used to treat partial onset seizures. The exact mechanism of action has not been described in the literature, though it positively modulates GABAA and inhibits voltage gated sodium channels. Cenobamate was granted FDA approval on 21 November 2019.
